Elkedonia is a series a startup based in France. 1 investor tracked.
Elkedonia is a company founded in 2022 headquartered in France. Its most recent tracked round is Series A. Brouky records 4 investors associated with the company.
Elkedonia develops a first-in-class antidepressant approach that leverages precision medicine, targeting the inhibition of the intracellular Elk1 protein to address treatment-resistant depression.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.